Who are the key players in the Krystexxa Market Report 2026 market?

Major companies operating in the Krystexxa Market Report 2026 market are Major companies operating in the krystexxa market are Amgen Inc. Read More

What are the major opportunities in the Krystexxa market? What are the strategies for the Krystexxa market?

For detailed insights on the major opportunities and strategies in the Krystexxa market, Read More

How does the Krystexxa market relate to the overall economy and other similar markets?

For detailed insights on Krystexxa's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Krystexxa market growth? SWOT analysis of the Krystexxa market.

For detailed insights on the key dynamics influencing the Krystexxa market growth and SWOT analysis of the Krystexxa industry, Read More

Krystexxa Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Krystexxa Market Report 2026

Name: Krystexxa Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Krystexxa Market Overview

• The Krystexxa market growth in the historic period has been driven by limitations of conventional gout therapies, increasing prevalence of chronic gout

• Market expansion is supported by growing refractory gout patient pool, increased referral to specialty clinics

• Growth Driver: Rising Gout Incidence Driving Growth In Krystexxa Market

• Market Trend: Innovative Advancing Immune-Modulating Therapies for Uncontrolled Gout

• North America was the largest region and fastest growing region.

What Is Covered Under Krystexxa Market?

Krystexxa (pegloticase) is a medication used to treat chronic gout in patients who are refractory to conventional therapies. It is an intravenous infusion that works by breaking down uric acid, thereby reducing uric acid levels in the body, which can help prevent gout attacks and related complications.

The main formulations in the krystexxa market are injectable formulation (lyophilized powder) and ready-to-use solutions. Krystexxa's injectable formulation, which is a lyophilized powder, refers to a freeze-dried form of the drug that is reconstituted with a diluent before administration. The various indications include treatment of chronic gout, management of hyperuricemia in gout patients, and treatment of refractory gout, and several patient demographics including adult patients, elderly patients and patients with comorbid conditions. Distribution channels for these treatments include direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, with end users such as hospitals, specialty clinics, rheumatology practices, and home healthcare providers.

Krystexxa Market Global Report 2026 Market Report bar graph

What Is The Krystexxa Market Size and Share 2026?

The growth in the historic period can be attributed to limitations of conventional gout therapies, increasing prevalence of chronic gout, clinical success of pegloticase, rising comorbid conditions, expansion of specialty rheumatology practices.

What Is The Krystexxa Market Growth Forecast?

The growth in the forecast period can be attributed to growing refractory gout patient pool, increased referral to specialty clinics, expansion of infusion services, supportive reimbursement for biologics, continued unmet need in severe gout. Major trends in the forecast period include growth in biologic therapies for refractory gout, focus on uric acid lowering enzyme treatments, specialty management of chronic gout patients, expansion of infusion based rheumatology care, rising use in severe and treatment resistant cases.

Book your 30 minutes free consultation with our research experts

Global Krystexxa Market Segmentation

1) By Formulation: Injectable Formulation (Lyophilized Powder), Ready-To-Use Solutions

2) By Indication: Treatment Of Chronic Gout, Management Of Hyperuricemia In Gout Patients, Treatment Of Refractory Gout

3) By Patient Demographics: Adult Patients, Elderly Patients, Patients With Comorbid Conditions

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Specialty Clinics, Rheumatology Practices, Home Healthcare Providers

What Is The Driver Of The Krystexxa Market?

The increasing incidence of gout disease is expected to propel the growth of the Krystexxa market going forward. Gout disease refers to a type of arthritis caused by the buildup of uric acid crystals in the joints, leading to inflammation, pain, and swelling. The increased incidence of gout disease is attributed to factors such as poor dietary habits, obesity, aging, certain medications, genetics, chronic kidney disease, a sedentary lifestyle, and comorbid conditions like high blood pressure and diabetes. Krystexxa (pegloticase) helps gout patients by lowering uric acid levels in the blood, specifically targeting chronic gout that is resistant to conventional treatments, thereby reducing the frequency and severity of gout flare-ups and providing relief from the painful symptoms associated with this condition. For instance, in June 2024, according to Rheumatology and Therapy, a US-based international peer-reviewed medical journal, the prevalence of comorbid gout and chronic kidney disease in the United States was projected to increase from 7.9 million in 2023 to 8.6 million in 2027, then to 9.2 million in 2031, and reaching 9.6 million in 2035, representing a 29% increase from 2023 to 2035. Therefore, the increasing incidence of gout disease is driving the krystexxa industry.

Key Players In The Global Krystexxa Market

Major companies operating in the krystexxa market are Amgen Inc.

Global Krystexxa Market Trends and Insights

Key trend in the krystexxa market is focusing on advancement of immunomodulatory strategies such as rheumatology research dissemination initiative to enhance clinical evidence visibility, support informed therapeutic decision-making, and strengthen stakeholder understanding of emerging advancements in inflammatory and autoimmune disease management. Rheumatology research dissemination initiative refers to a structured scientific communication effort aimed at presenting, sharing, and promoting new clinical findings, therapeutic data, and investigational insights within the field of rheumatology. For instance, in June 2024, Amgen Inc., a US-based biotechnology company, presented innovative rheumatology research at the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress, highlighting new clinical data related to Krystexxa (pegloticase). The research showcased expanded evidence on treatment response patterns, patient-reported outcomes, and immunologic behavior when using advanced therapeutic combinations. Krystexxa, a PEGylated uricase enzyme therapy, continues to demonstrate unique clinical benefits for adults with uncontrolled chronic gout by leveraging precision immune modulation to improve efficacy and manage anti-drug antibody formation. These new insights presented by Amgen reinforce Krystexxa’s role as a leading biologic option for patients with severe gout who have not responded adequately to conventional therapies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Krystexxa Market?

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics Plc for $27.8 billion. With the acquisition of Horizon Therapeutics, Amgen Inc. aims to significantly strengthen its position in the rare disease and inflammation market. Horizon Therapeutics Plc is an Ireland-based biopharmaceutical company that specializes in providing Krystexxa.

Regional Insights

North America was the largest region in the krystexxa market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Krystexxa Market?

The krystexxa market consists of sales of pegloticase and infusion kits sales. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Krystexxa Market Report 2026?

The krystexxa market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the krystexxa industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Krystexxa Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Formulation, Indication, Patient Demographics, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Amgen Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Krystexxa Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Krystexxa Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Krystexxa Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Krystexxa Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growth In Biologic Therapies For Refractory Gout

4.2.2 Focus On Uric Acid Lowering Enzyme Treatments

4.2.3 Specialty Management Of Chronic Gout Patients

4.2.4 Expansion Of Infusion Based Rheumatology Care

4.2.5 Rising Use In Severe And Treatment Resistant Cases

5. Krystexxa Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Rheumatology Practices

5.4 Infusion Centers

5.5 Academic Medical Centers

6. Krystexxa Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Krystexxa Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Krystexxa PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Krystexxa Market Size, Comparisons And Growth Rate Analysis

7.3. Global Krystexxa Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Krystexxa Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Krystexxa Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Krystexxa Market Segmentation

9.1. Global Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Formulation (Lyophilized Powder), Ready-To-Use Solutions

9.2. Global Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Treatment Of Chronic Gout, Management Of Hyperuricemia In Gout Patients, Treatment Of Refractory Gout

9.3. Global Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Elderly Patients, Patients With Comorbid Conditions

9.4. Global Krystexxa Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

9.5. Global Krystexxa Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Rheumatology Practices, Home Healthcare Providers

10. Krystexxa Market Regional And Country Analysis

10.1. Global Krystexxa Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Krystexxa Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Krystexxa Market

11.1. Asia-Pacific Krystexxa Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Krystexxa Market

12.1. China Krystexxa Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Krystexxa Market

13.1. India Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Krystexxa Market

14.1. Japan Krystexxa Market Overview

14.2. Japan Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Krystexxa Market

15.1. Australia Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Krystexxa Market

16.1. South Korea Krystexxa Market Overview

16.2. South Korea Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Krystexxa Market

17.1. Western Europe Krystexxa Market Overview

17.2. Western Europe Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Krystexxa Market

18.1. UK Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Krystexxa Market

19.1. Germany Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Krystexxa Market

20.1. France Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Krystexxa Market

21.1. Eastern Europe Krystexxa Market Overview

21.2. Eastern Europe Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Krystexxa Market

22.1. North America Krystexxa Market Overview

22.2. North America Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Krystexxa Market

23.1. USA Krystexxa Market Overview

23.2. USA Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Krystexxa Market

24.1. Canada Krystexxa Market Overview

24.2. Canada Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Krystexxa Market

25.1. South America Krystexxa Market Overview

25.2. South America Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Krystexxa Market

26.1. Middle East Krystexxa Market Overview

26.2. Middle East Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Krystexxa Market

27.1. Africa Krystexxa Market Overview

27.2. Africa Krystexxa Market, Segmentation By Formulation, Segmentation By Indication, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Krystexxa Market Regulatory and Investment Landscape

29. Krystexxa Market Competitive Landscape And Company Profiles

29.1. Krystexxa Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Krystexxa Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Krystexxa Market Company Profiles

29.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Krystexxa Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Krystexxa Market

32. Krystexxa Market High Potential Countries, Segments and Strategies

32.1 Krystexxa Market In 2030 - Countries Offering Most New Opportunities

32.2 Krystexxa Market In 2030 - Segments Offering Most New Opportunities

32.3 Krystexxa Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Krystexxa Market, Overview Of Key Products - Product Examples

Table 2: Global Krystexxa Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Krystexxa Market, Supply Chain Analysis

Table 4: Global Krystexxa Market, Major Raw Material Providers

Table 5: Global Krystexxa Market, Major Resource Providers

Table 6: Global Krystexxa Market, Major Manufacturers (Suppliers)

Table 7: Global Krystexxa Market, Major Distributors And Channel Partners

Table 8: Global Krystexxa Market, Key Technologies & Future Trends

Table 9: Global Krystexxa Market, Major Trends

Table 10: Global Krystexxa Market, Major End Users

Table 11: Global Krystexxa Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Krystexxa Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Krystexxa Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Krystexxa Market - TAM, US$ Billion, 2025

Table 15: Global Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Krystexxa Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Krystexxa Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Krystexxa Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Krystexxa Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: South Korea, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: South Korea, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Western Europe, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Western Europe, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: UK, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: UK, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Germany, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Germany, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: France, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: France, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Eastern Europe, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Eastern Europe, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: North America, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: North America, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: USA, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: USA, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Canada, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Canada, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: South America, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: South America, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Middle East, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Middle East, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Africa, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Africa, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Global Krystexxa Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 74: Global Krystexxa Market - Company Scoring Matrix

Table 75: Amgen Inc. Financial Performance

Table 76: Global Krystexxa Market, Competitive Benchmarking (In USD Billions)

Table 77: Global Krystexxa Market, Competitive Dashboard

Table 78: Global Krystexxa Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 79: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Table 80: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 81: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

Figure 1: Global Krystexxa Market, Overview Of Key Products - Product Examples

Figure 2: Global Krystexxa Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Krystexxa Market, Supply Chain Analysis

Figure 4: Global Krystexxa Market, Major Raw Material Providers

Figure 5: Global Krystexxa Market, Major Resource Providers

Figure 6: Global Krystexxa Market, Major Manufacturers (Suppliers)

Figure 7: Global Krystexxa Market, Major Distributors And Channel Partners

Figure 8: Global Krystexxa Market, Key Technologies & Future Trends

Figure 9: Global Krystexxa Market, Major Trends

Figure 10: Global Krystexxa Market, Major End Users

Figure 11: Global Krystexxa Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Krystexxa Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Krystexxa Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Krystexxa Market - TAM, US$ Billion, 2025

Figure 15: Global Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Krystexxa Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Krystexxa Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Krystexxa Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Krystexxa Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: South Korea, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: South Korea, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Western Europe, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Western Europe, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: UK, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: UK, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Germany, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Germany, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: France, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: France, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Eastern Europe, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Eastern Europe, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: North America, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: North America, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: USA, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: USA, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Canada, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Canada, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: South America, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: South America, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Middle East, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Middle East, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Krystexxa Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Africa, Krystexxa Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Africa, Krystexxa Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Global Krystexxa Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 74: Global Krystexxa Market - Company Scoring Matrix

Figure 75: Amgen Inc. Financial Performance

Figure 76: Global Krystexxa Market, Competitive Benchmarking (In USD Billions)

Figure 77: Global Krystexxa Market, Competitive Dashboard

Figure 78: Global Krystexxa Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 79: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Figure 80: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 81: Global, Krystexxa Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

Biopreservation Market Report 2026 - Global Outlook – By Type (Biopreservation Equipment, Biopreservation Media), By Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), By Application (Therapeutic...

Financial Analytics Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment Mode (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium Sized Enterprises), By Applic...

Koi Market Report 2026 - Global Outlook – By Type (Kohaku, Taisho Sanke, Showa Sanke, Other Types), By Size (Small, Medium, Large), By Distribution Channel (Online, Offline), By End-User (Commercial, Retail, Residential)...

Potassium Iodide Market Report 2026 - Global Outlook – By Product Type (Solid, Liquid), By Grade (Industrial Grade, Pharmaceutical Grade, Feed Grade), By Application (Pharmaceutical Industry, Nutritional Supplements, Ind...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Frequently Asked Questions

How big is the Krystexxa Market?

The Krystexxa market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Krystexxa market growth?

The global Krystexxa market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Krystexxa market?

Some Key Players in the Krystexxa market Include, Amgen Inc. .

What is the anticipated growth trend for the Krystexxa market?

Major trend in this market includes: Innovative Advancing Immune-Modulating Therapies for Uncontrolled Gout . For further insights on this market. request a sample here

Which region has the most growth potential in the Krystexxa market?

North America was the largest region in the krystexxa market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the krystexxa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.